IFP Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.42K | Buy |
2,090
+90
| +5% | +$390 | ﹤0.01% | 3388 |
|
|
2025
Q4 | $7.12K | Hold |
2,000
| – | – | ﹤0.01% | 3236 |
|
|
2025
Q3 | $17.8K | Sell |
2,000
-12
| -0.6% | -$122 | ﹤0.01% | 2639 |
|
|
2025
Q2 | $18.6K | Buy |
2,012
+10
| +0.5% | +$85 | ﹤0.01% | 2590 |
|
|
2025
Q1 | $17.2K | Sell |
2,002
-35
| -2% | -$330 | ﹤0.01% | 2355 |
|
|
2024
Q4 | $21.9K | Buy |
2,037
+37
| +2% | +$285 | ﹤0.01% | 2208 |
|
|
2024
Q3 | $11.4K | Hold |
2,000
| – | – | ﹤0.01% | 2373 |
|
|
2024
Q2 | $8.44K | Hold |
2,000
| – | – | ﹤0.01% | 2399 |
|
|
2024
Q1 | $10.2K | Hold |
2,000
| – | – | ﹤0.01% | 2228 |
|
|
2023
Q4 | $18.6K | Hold |
2,000
| – | – | ﹤0.01% | 1947 |
|
|
2023
Q3 | $13.1K | Hold |
2,000
| – | – | ﹤0.01% | 2148 |
|
|
2023
Q2 | $16.3K | Hold |
2,000
| – | – | ﹤0.01% | 2109 |
|
|
2023
Q1 | $2.9K | Sell |
2,000
-1,000
| -33% | -$9.98K | ﹤0.01% | 2774 |
|
|
2022
Q4 | $4K | Sell |
3,000
-1,000
| -25% | -$10.7K | ﹤0.01% | 3853 |
|
|
2022
Q3 | $5K | Hold |
4,000
| – | – | ﹤0.01% | 3995 |
|
|
2022
Q2 | $5K | Hold |
4,000
| – | – | ﹤0.01% | 3750 |
|
|
2022
Q1 | $5K | Buy |
4,000
+2,000
| +100% | +$24.6K | ﹤0.01% | 3750 |
|
|
2021
Q4 | $35K | Hold |
2,000
| – | – | ﹤0.01% | 1687 |
|
|
2021
Q3 | $36K | Hold |
2,000
| – | – | ﹤0.01% | 1712 |
|
|
2021
Q2 | $46K | Hold |
2,000
| – | – | ﹤0.01% | 1565 |
|
|
2021
Q1 | $30K | Sell |
2,000
-2,000
| -50% | -$21.8K | ﹤0.01% | 1658 |
|
|
2020
Q4 | $22K | Hold |
4,000
| – | – | ﹤0.01% | 1750 |
|
|
2020
Q3 | $18K | Hold |
4,000
| – | – | ﹤0.01% | 1684 |
|
|
2020
Q2 | $20K | Hold |
4,000
| – | – | ﹤0.01% | 1563 |
|
|
2020
Q1 | $12K | Buy |
+4,000
| New | +$13.9K | ﹤0.01% | 1686 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2878 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3106 |
|
Other funds holding AVXL
VCM
SF
VPM